The user facility did not allege that the device caused or contributed to patient injury or malfunctioned.Jada expulsion was likely secondary to vomiting as reported by the facility.No additional treatment for bleeding was required following the expulsion of the device.No injury or adverse events related to the expulsion of the device were reported.We do not believe that jada malfunctioned based on the information available at this time, but out of an abundance of caution and because we cannot rule it out at this time we are reporting this event due to the 30 day reporting deadline.If we become aware of additional information, we will supplement this report.The submission of this report is not an admission that the device caused or contributed to the reported event.
|
The patient was noted to have abnormal postpartum bleeding related to uterine atony after her delivery.Prior to jada insertion she received carboprost (1 dose), methergine (1 dose), and misoprostol.Estimated blood loss at time of jada insertion was noted as 600 ml.The report states jada was inserted, and 10 minutes after treatment was initiated, the patient vomited and expelled the device.The total amount of blood collected in the vacuum canister was noted as 20 ml.The report stated that, "the fundus was determined to be firm without additional bleeding, therefore the team determined not to re-insert the jada device." the total cumulative blood loss for this event was reported at 620 ml and bleeding was controlled.The patient was also reported as having received intrapartum antibiotics as she was positive for group b strep (gbs).
|